Ketamine Anesthesia in Electroconvulsive Therapy
Open Access
- 18 November 2021
- book chapter
- Published by IntechOpen
Abstract
Electroconvulsive therapy (ECT) is highly effective both Major Depressive Disorder (MDD) and Bipolar Disorder (BD). Ketamine, an antagonist of the N-Methyl-D-aspartate receptor, has been described to have antidepressant properties. There is a hypothesis that ECT performed with anesthesia using ketamine is more effective than conventional ECT. Also, although ECT is the gold standard for BD and MDD, there are questions about which is more effective, ketamine treatment or ECT, and whether ketamine is more effective when used in combination with ECT. In this chapter, we review the current literature on the effectiveness of ECT and ketamine. Furthermore, we discuss whether ketamine can be an alternative treatment to ECT for patients with TRD.Keywords
This publication has 42 references indexed in Scilit:
- Effects of S-Ketamine as an Anesthetic Adjuvant to Propofol on Treatment Response to Electroconvulsive Therapy in Treatment-Resistant DepressionThe Journal of ECT, 2013
- Serial infusions of low-dose ketamine for major depressionJournal of Psychopharmacology, 2013
- Electroconvulsive Therapy in ChinaThe Journal of ECT, 2012
- Neuropsychological and mood effects of ketamine in electroconvulsive therapy: A randomised controlled trialJournal of Affective Disorders, 2012
- Rapid Antidepressant Effect of Ketamine in the Electroconvulsive Therapy SettingThe Journal of ECT, 2012
- Effects of Propofol and Ketamine as Combined Anesthesia for Electroconvulsive Therapy in Patients With Depressive DisorderThe Journal of ECT, 2012
- Ketofol in electroconvulsive therapy anesthesia: two stones for one birdJournal of Anesthesia, 2012
- Course of Improvement in Depressive Symptoms to a Single Intravenous Infusion of Ketamine vs Add-on Riluzole: Results from a 4-Week, Double-Blind, Placebo-Controlled StudyNeuropsychopharmacology, 2012
- Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant DepressionBiological Psychiatry, 2010
- Report by the ACNP Task Force on Response and Remission in Major Depressive DisorderNeuropsychopharmacology, 2006